Search Results 1301-1310 of 19945 for Receptor

1. A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer - Mayo Clinic

   Estrogen Receptor (ER)-, Progesterone Receptor (PR)-, and Human Epidermal Growth Factor Receptor (HER)2-negative (triple-negative) cancer of the breast.

2. A Study to Evaluate the Effectiveness and Safety of PANZYGA in Pediatric Patients with Chronic Immune Thrombocytopenia (ITP) - Mayo Clinic

   Administration of thrombopoietin receptor agonists when the dose has NOT been stable within 3 weeks before enrollment and a dosage change is planned before Day ...

3. Attack the Gap-New Immunotherapy May Help the Body Fight Ovarian Cancer

   The phase I trial targets a specific protein, folate receptor alpha, in the cancer cells. It also uses a specific type of T cell, Th17, to trigger an immune ...

4. High blood pressure and cold remedies: Which are safe? - Mayo Clinic

   Angiotensin II receptor blockers · Angiotensin-converting enzyme (ACE) inhibitors · Anxiety: A cause of high blood pressure? Arteriosclerosis / atherosclerosis ...

5. Publications - Reade A. Quinton, M.D. - Mayo Clinic

   Epub 2020 Nov 16. View PubMed; Shahi M, Mamber Czeresnia R, Cheek EH, Quinton RA, Chakraborty R, Enninga EAL. Expression of Immune Checkpoint Receptors in ...

6. A Study Of CNTO 136 (Sirukumab), A Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, In Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

   Has a history of intolerance to tocilizumab that precluded further treatment with it, or inadequate response to 3 months of tocilizumab (anti-IL-6 receptor) ...

7. Cancer to COVID-19: Experimental treatment pivots in record time - Mayo Clinic News Network

   B., a Mayo Clinic cancer researcher, studies a type of cancer therapy called chimeric antigen receptor-T cell therapy, or CAR-T cell therapy. It was hailed ...

8. A Study to Analyze SAR442168 in Participants with Nonrelapsing Secondary Progressive Multiple Sclerosis - Mayo Clinic

   A history of T-lymphocyte or T-lymphocyte-receptor vaccination, transplantation (including solid organ, stem cell, and bone marrow transplantation) and/or ...

9. Is your teen depressed? - Mayo Clinic News Network

   When these chemicals are abnormal or impaired, the function of nerve receptors and nerve systems changes, leading to depression. Hormones. Changes in the ...

10. Infectious Diseases! Clinical Trials - Mayo Clinic Research

    This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...